KDM1A and cancer: Combination therapy with LSD1 inhibitors and 5-FU strongly inhibited Wnt/β-Catenin signalling and DNA synthesis, significantly inhibiting the proliferation, migration, and growth of cancer cells in a tumor xenograft-bearing model (Peng et al., 2020).